{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:11:09Z","timestamp":1768288269325,"version":"3.49.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1053\/beha.2002.0230","type":"journal-article","created":{"date-parts":[[2003,3,4]],"date-time":"2003-03-04T18:13:53Z","timestamp":1046801633000},"page":"713-728","source":"Crossref","is-referenced-by-count":37,"title":["Treatment of lymphoblastic lymphoma in adults"],"prefix":"10.1053","volume":"15","author":[{"given":"Dieter","family":"Hoelzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"G\u00f6kbuget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2002.0230_RF1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0230_RF2","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995","volume":"92","author":"Groves","year":"2000","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1053\/beha.2002.0230_RF3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2559.2000.00895.x","article-title":"The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997","volume":"36","author":"Harris","year":"2000","journal-title":"Histopathology"},{"key":"10.1053\/beha.2002.0230_RF4","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","article-title":"Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia","volume":"99","author":"Hoelzer","year":"2002","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0230_RF5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/1097-0142(19810115)47:2<280::AID-CNCR2820470212>3.0.CO;2-E","article-title":"Immunologic classification of childhood acute lymphocytic leukemia","volume":"47","author":"Foon","year":"1981","journal-title":"Cancer"},{"key":"10.1053\/beha.2002.0230_RF6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.7326\/0003-4819-89-3-415","article-title":"Lymphoblastic lymphoma, a term rekindled with new precision","volume":"89","author":"Jaffe","year":"1978","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/beha.2002.0230_RF7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/oxfordjournals.annonc.a057692","article-title":"Lymphoblastic lymphoma in adult patients: Clinicopathological features and response to intensive multiagent chemotherapy analogous to that used in acute lymphoblastic leukemia","volume":"1","author":"Bernasconi","year":"1990","journal-title":"Annals of Oncology"},{"key":"10.1053\/beha.2002.0230_RF8","first-page":"42","article-title":"Autologous bone marrow transplantation for adult advanced stage lymphoblastic lymphoma in first CR. A study of the NHLCSG","volume":"5","author":"Santini","year":"1991","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0230_RF9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.1992.10.7.1078","article-title":"Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients","volume":"10","author":"Morel","year":"1992","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0230_RF10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/10428199609054867","article-title":"Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients","volume":"23","author":"Zinzani","year":"1996","journal-title":"Leukemia & Lymphoma"},{"key":"10.1053\/beha.2002.0230_RF11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1023\/A:1008202808144","article-title":"Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center","volume":"9","author":"Bouabdallah","year":"1998","journal-title":"Annals of Oncology"},{"key":"10.1053\/beha.2002.0230_RF12","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1200\/JCO.2001.19.11.2927","article-title":"High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation\/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group","volume":"19","author":"Sweetenham","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0230_RF13","first-page":"416","article-title":"Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report","volume":"95","author":"Reiter","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0230_RF14","first-page":"2926a","article-title":"Characteristics, outcome and risk factors in adult T-lineage acute lymphoblastic leukemia (ALL)","volume":"94","author":"Hoelzer","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0230_RF15","first-page":"1391a","article-title":"Lymphoblastic lymphoma: results of a prospective treatment trial (BMFT study)","volume":"93","author":"Engelhard","year":"1996","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0230_RF16","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2648::AID-CNCR22>3.0.CO;2-R","article-title":"B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology","volume":"85","author":"Soslow","year":"1999","journal-title":"Cancer"},{"key":"10.1053\/beha.2002.0230_RF17","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1309\/Q5GV-3K00-WAC6-BBUB","article-title":"Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature","volume":"115","author":"Maitra","year":"2001","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1053\/beha.2002.0230_RF18","first-page":"332","article-title":"Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults","volume":"7","author":"Murphy","year":"1980","journal-title":"Seminars in Oncology"},{"key":"10.1053\/beha.2002.0230_RF19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1182\/blood.V57.1.186.186","article-title":"The chemotherapy of lymphoblastic lymphoma","volume":"57","author":"Voakes","year":"1981","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0230_RF20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF00686341","article-title":"Intensive chemotherapy for adult lymphoblastic lymphomas","volume":"29","author":"Liang","year":"1991","journal-title":"Cancer Chemotherapy & Pharmacology"},{"key":"10.1053\/beha.2002.0230_RF21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10428199909145953","article-title":"Non-Hodgkin's lymphoma protocols in the treatment of patients with Burkitt's lymphoma and lymphoblastic lymphoma: a report on 58 patients","volume":"36","author":"Kaiser","year":"1999","journal-title":"Leukemia & Lymphoma"},{"key":"10.1053\/beha.2002.0230_RF22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1182\/blood.V57.4.679.679","article-title":"Lymphoblastic lymphoma in adults: results of a pilot protocol","volume":"57","author":"Coleman","year":"1981","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0230_RF23","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1200\/JCO.1986.4.11.1628","article-title":"Treatment of lymphoblastic lymphoma in adults","volume":"4","author":"Coleman","year":"1986","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0230_RF24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/10428199409049726","article-title":"Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma","volume":"15","author":"Colgan","year":"1994","journal-title":"Leukemia & Lymphoma"},{"key":"10.1053\/beha.2002.0230_RF25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s002770100363","article-title":"Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients","volume":"80","author":"Chen","year":"2001","journal-title":"Annals of Hematology"},{"key":"10.1053\/beha.2002.0230_RF26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1182\/blood.V61.1.92.92","article-title":"Successful therapy of convoluted T-lymphoblastic lymphoma in the adult","volume":"61","author":"Levine","year":"1983","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0230_RF27","first-page":"106","article-title":"Lymphoblastic lymphoma (LBL) and acute lymphoblastic leukaemia (ALL) in adults: relationships and therapeutic perspectives","volume":"4","author":"Santini","year":"1989","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0230_RF28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1200\/JCO.1986.4.1.57","article-title":"Lymphoblastic lymphoma in adults","volume":"4","author":"Slater","year":"1986","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0230_RF29","first-page":"754a","article-title":"Acute lymphoblastic leukemia: single center experience with modified chemotherapy","volume":"86","author":"Daenen","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0230_RF30","first-page":"38a","article-title":"Outcome with the hyper-CVAD regimen in lymphoblastic lymphoma","volume":"18","author":"Thomas","year":"1999","journal-title":"Proc ASCO"},{"key":"10.1053\/beha.2002.0230_RF31","first-page":"2269","article-title":"Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas","volume":"17","author":"Yeh","year":"1997","journal-title":"Anticancer Research"},{"key":"10.1053\/beha.2002.0230_RF32","first-page":"559","article-title":"Childhood non-Hodgkin's lymphoma: the results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)","volume":"308","author":"Anderson","year":"1983","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0230_RF33","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/0277-5379(88)90053-3","article-title":"Lymphoblastic lymphoma in adults: a clinicopathological study of 34 cases treated at the Institut Gustave-Roussy","volume":"24","author":"Salloum","year":"1988","journal-title":"European Journal of Cancer and Clinical Oncology"},{"key":"10.1053\/beha.2002.0230_RF34","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/bjc.1995.405","article-title":"Childhood T-cell lymphoblastic lymphoma--does early resolution of mediastinal mass predict for final outcome?","volume":"72","author":"Shepherd","year":"1995","journal-title":"British Journal of Cancer"},{"key":"10.1053\/beha.2002.0230_RF35","first-page":"3294","article-title":"Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin\u2013Frankfurt\u2013Munster Group Trial NHL-BFM 90","volume":"94","author":"Reiter","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0230_RF36","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1200\/JCO.2001.19.2.414","article-title":"Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F] FDG-PET a valid alternative to conventional diagnostic methods?","volume":"19","author":"Spaepen","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0230_RF37","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1182\/blood.V94.10.3289.422k32_3289_3293","article-title":"Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients","volume":"94:","author":"Zinzani","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0230_RF38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/bjc.1984.202","article-title":"Adjuvant low dose radiation in childhood non-Hodgkin's lymphoma (report from the United Kingdom Childrens\u2019 Cancer Study Group--UKCCSG)","volume":"50","author":"Mott","year":"1984","journal-title":"British Journal of Cancer"},{"key":"10.1053\/beha.2002.0230_RF39","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1200\/JCO.1995.13.6.1368","article-title":"Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study","volume":"13","author":"Tubergen","year":"1995","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0230_RF40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1200\/JCO.1988.6.1.26","article-title":"Lymphoblastic lymphoma in children--a randomized trial comparing LSA2-L2 with the A-COP+therapeutic regimen: a Pediatric Oncology Group Study","volume":"6","author":"Hvizdala","year":"1988","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0230_RF41","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/1097-0142(19850815)56:4<738::AID-CNCR2820560406>3.0.CO;2-O","article-title":"Effectiveness of a six-drug regimen (APO) without local irradiation for treatment of mediastinal lymphoblastic lymphoma in children","volume":"56","author":"Camitta","year":"1985","journal-title":"Cancer"},{"key":"10.1053\/beha.2002.0230_RF42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.1983.1.9.537","article-title":"Long-term results of the APO protocol (vincristine, doxorubicin [adriamycin], and prednisone) for treatment of mediastinal lymphoblastic lymphoma","volume":"1","author":"Weinstein","year":"1983","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0230_RF43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood.V58.1.52.52","article-title":"Immunoblastic sarcoma of T-cell versus B-cell origin: I. Clinical features","volume":"58","author":"Levine","year":"1981","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0230_RF44","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/oxfordjournals.annonc.a059214","article-title":"Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients","volume":"6","author":"Jost","year":"1995","journal-title":"Annals of Oncology"},{"key":"10.1053\/beha.2002.0230_RF45","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0277-5379(86)90087-8","article-title":"Lymphoblastic lymphoma in adolescents and adults. Clinical, pathological and prognostic evaluation","volume":"22","author":"Mazza","year":"1986","journal-title":"European Journal of Cancer and Clinical Oncology"},{"key":"10.1053\/beha.2002.0230_RF46","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329:","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0230_RF47","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1182\/blood.V92.12.4491","article-title":"Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor","volume":"92","author":"Armitage","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0230_RF48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1053\/beha.2002.0230_RF49","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2141.1989.tb00224.x","article-title":"Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission","volume":"73","author":"Milpied","year":"1989","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0230_RF50","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.1992.10.4.644","article-title":"Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission","volume":"10","author":"Verdonck","year":"1992","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0230_RF51","first-page":"33","article-title":"Autologous bone marrow transplantation in 22 adult patients with lymphoblastic lymphoma responsive to conventional dose chemotherapy","volume":"10","author":"Baro","year":"1992","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0230_RF52","first-page":"2130a","article-title":"Autologous stem cell transplantation (ASCT) for lymphoblastic lymphoma (LBL)","volume":"94","author":"Conde","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0230_RF53","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.1994.12.7.1358","article-title":"High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation","volume":"12","author":"Sweetenham","year":"1994","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0230_RF54","first-page":"1121a","article-title":"Allogeneic transplantation for lymphoma produces a lower relapse rate than autologous transplantation but survival is worse because of higher treatment related mortality \u2013 a report of 764 cases from the EBMT lymphoma registry","volume":"90","author":"Peniket","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0230_RF55","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9343(97)89488-0","article-title":"Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology","volume":"100","author":"van Besien","year":"1996","journal-title":"American Journal of Medicine"},{"key":"10.1053\/beha.2002.0230_RF56","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1200\/JCO.1996.14.11.3036","article-title":"Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies","volume":"14","author":"van Besien","year":"1996","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0230_RF57","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/1097-0142(19871115)60:10<2366::AID-CNCR2820601003>3.0.CO;2-U","article-title":"Cytosine arabinoside\/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia","volume":"60","author":"Lauer","year":"1987","journal-title":"Cancer"},{"key":"10.1053\/beha.2002.0230_RF58","series-title":"Acute Lymphoblastic Leukemia","first-page":"221","article-title":"Intensified chemotherapy and mediastinal irradiation in adult T-cell acute lymphoblastic leukemia","author":"Hoelzer","year":"1990"},{"key":"10.1053\/beha.2002.0230_RF59","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.leu.2401310","article-title":"Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study","volume":"13","author":"Amylon","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0230_RF60","first-page":"3310","article-title":"Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90","volume":"95","author":"Schrappe","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0230_RF61","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.leu.2402111","article-title":"International Childhood Acute Lymphoblastic Leukemia Workshop: Sausalito, CA, 30 November\u20131 December 2000","volume":"15","author":"Pui","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0230_RF62","first-page":"1088","article-title":"Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study","volume":"84","author":"Bassan","year":"1999","journal-title":"Haematologica"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692602902306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692602902306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T19:49:27Z","timestamp":1584474567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692602902306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["S1521692602902306"],"URL":"https:\/\/doi.org\/10.1053\/beha.2002.0230","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}